Enzo Biochem, Inc.
ENZB
$0.5299
-$0.01-1.85%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.08M | -21.31M | -22.84M | -26.08M | 44.73M |
| Total Depreciation and Amortization | 1.35M | 1.37M | 1.32M | 1.27M | 1.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.86M | 5.66M | 4.76M | 6.80M | -76.36M |
| Change in Net Operating Assets | 553.00K | -687.00K | -5.12M | -8.25M | -12.06M |
| Cash from Operations | -15.32M | -14.96M | -21.88M | -26.26M | -42.21M |
| Capital Expenditure | -1.03M | -784.00K | -739.00K | -545.00K | -995.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.00M | 5.00M | 5.00M | -- | -- |
| Cash from Investing | 3.97M | 4.22M | 4.26M | -545.00K | 100.75M |
| Total Debt Issued | -- | -- | -- | -- | 16.28M |
| Total Debt Repaid | -3.69M | -3.68M | -3.71M | -3.72M | -20.63M |
| Issuance of Common Stock | -- | -- | -- | -- | 386.00K |
| Repurchase of Common Stock | -163.00K | -170.00K | -170.00K | -474.00K | -474.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.32M | -5.32M | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9.18M | -9.18M | -3.88M | -4.19M | -4.82M |
| Foreign Exchange rate Adjustments | 60.00K | -20.00K | 17.00K | -5.00K | -192.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.46M | -19.94M | -21.47M | -31.00M | 53.52M |